Bioequivalence of trimetazidine dihydrochloride tablets in Chinese healthy subjects
XU Li,SONG Dan,HU Tian-ze,LIU Man,ZHAO Zhi-jing,LIU Hui-chen
DOI: https://doi.org/10.13699/j.cnki.1001-6821.2023.08.023
2023-01-01
Abstract:Objective To evaluate the bioequivalence of two kinds of trimetazidine hydrochloride tablets in healthy Chinese volunteers.Methods This is a single-center,single-dose,randomized,open,two-period,cross-over pharmacokinetic study.A total of 20 subjects in fasting state and 28 subjects in fed state were given single oral dose of test and reference preparation of trimetazidine hydrochloride tablets （each20 mg）,respectively.The concentration of trimetazidine in human plasma was measured by LC-MS/MS.Results The main pharmacokinetic parameters oftrimetazidine of the test and reference preparations were as follows:In fasting state,C max were（52.38±13.99）,（55.04±18.45） ng·mL -1 ,AUC 0-t were（490.40±127.60）,（474.41±125.76） ng·h·mL -1 ,AUC 0-∞ were（507.47±137.40）,（489.47±134.74） ng·h·mL -1 ;In fed state,C max were （60.27±12.12）,（57.54±10.55） ng·mL -1 ,AUC 0-t were （486.51±113.42）,（471.30±106.74）ng·h·mL -1 ,AUC 0-∞ were （504.86±125.75）,（489.28±119.22） ng·h·mL -1 .Under fasting and postprandial conditions,the 90%confidence intervals ofC max ,AUC 0-t and AUC 0-∞ of the test preparation and thereference preparation were within the equivalent of 80.00%to 125.00%.The incidences of adverse events in the fasting and fed groups were 10.00%（2 cases/20 cases） and 7.14%（2 cases/28 cases）,respectively,and no serious adverse events and unanticipated adverse events occurred during the course of the trial.Conclusion Two kinds of trimetazidine hydrochloride tables were bioequivalent in healthy Chinese volunteers under fasting and fed conditions.